Cargando…
Enhancing the sialylation of recombinant EPO produced in CHO cells via the inhibition of glycosphingolipid biosynthesis
Sialylation regulates the in vivo half-life of recombinant therapeutic glycoproteins, affecting their therapeutic efficacy. Levels of the precursor molecule cytidine monophospho-N-acetylneuraminic acid (CMP-Neu5Ac) are considered a limiting factor in the sialylation of glycoproteins. Here, we show t...
Autores principales: | Kwak, Chan-Yeong, Park, Seung-Yeol, Lee, Chung-Geun, Okino, Nozomu, Ito, Makoto, Kim, Jung Hoe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5638827/ https://www.ncbi.nlm.nih.gov/pubmed/29026192 http://dx.doi.org/10.1038/s41598-017-13609-4 |
Ejemplares similares
-
Inhibition of poly-LacNAc biosynthesis with release of CMP-Neu5Ac feedback inhibition increases the sialylation of recombinant EPO produced in CHO cells
por: Lee, Chung-Geun, et al.
Publicado: (2018) -
Understanding and Controlling Sialylation in a CHO Fc-Fusion Process
por: Lewis, Amanda M., et al.
Publicado: (2016) -
Production of IgGs with a human-like sialylation in CHO cells
por: Raymond, Céline, et al.
Publicado: (2015) -
Ion Mobility Mass Spectrometry Reveals Rare Sialylated Glycosphingolipid Structures in Human Cerebrospinal Fluid
por: Sarbu, Mirela, et al.
Publicado: (2022) -
Production of α2,6-sialylated IgG1 in CHO cells
por: Raymond, Céline, et al.
Publicado: (2015)